To ensure effective supplementation t ailored to each individuals needs, the THERASCIENCE Laboratory offers a wide range of single-ingredient formulas, always guaranteeing product quality and the efficacy of its active ingredients
However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
Most clinical studies tracked by the NIH show that patients can lose a significant percentage of their body weight over the first six to twelve months
doi:10.1007/s00405-014-3175-3 Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS
These weight-loss drugs also differ in their active ingredients, dosages, potential side effects, and costs